ISSN : 0970 - 020X, ONLINE ISSN : 2231-5039
     FacebookTwitterLinkedinMendeley

Synthesis, Properties and Biological Effectiveness of Iron Oxide Nanoparticles Via Calcinations Method

Maged S. Al-Fakeh

Department of Chemistry, Faculty of Science, Qassim University, Saudi Arabia

Corresponding Author E-mail: m.alfakeh@qu.edu.sa

DOI : http://dx.doi.org/10.13005/ojc/360123

Article Publishing History
Article Received on : 23 Dec 2019
Article Accepted on : 28 Jan 2020
Article Published : 07 Feb 2020
Article Metrics
ABSTRACT:

In this study, an iron oxide nanoparticles (IONPs) was carried out via a calcinations method for a coordination polymers of iron derived from terephthalate and 2-aminothiazole. The iron oxide nanoparticles were described by FT-IR, XRD, transmission electron microscopy(T.E.M) and scanning electron microscopy(S.E.M). The thermodynamic and kinetic variables ∆H*, ∆S* and ∆G* for the iron complex is calculated. The optical properties were investigated by UV–vis and fluorescence techniques. From SEM and TEM observations, the morphology shape and size of the iron oxide nanoparticles is estimated to be significantly smaller than 32 nm. The biological effectiveness of the IO NPs was tested successfully against some fungal and bacterial species.

KEYWORDS:

(IONPs) Iron Oxide Nanoparticles; SEM; TEM microscopy; XRD.

Download this article as: 

Copy the following to cite this article:

Al-Fakeh M. S. Synthesis, Properties and Biological Effectiveness of Iron Oxide Nanoparticles Via Calcinations Method. Orient J Chem 2020;36(1).


Copy the following to cite this URL:

Al-Fakeh M. S. Synthesis, Properties and Biological Effectiveness of Iron Oxide Nanoparticles Via Calcinations Method. Orient J Chem 2020;36(1). Available from: https://bit.ly/2OALAXh


Introduction

Iron oxide nanoparticles (IONPs) are the inorganic compound, non-toxicity and can also easily be prepared in the laboratory. The existence of amorphous iron oxide (Fe2O3) and four polymorphs alpha, beta, gamma and epsilon is well established. IONPs exhibit high saturation magnetization, biosensing, superparamagnetic properties, drug-delivery,  leading to their biomedical applications such as anti-microbial (anti-bacterial, anti-fungal, magnetic sensing probes for in-vitro diagnostics and tumor targeting [16] In addition to this, they show interesting find applications in magnetic data storage [7-12]. In (NPs) nanoparticles, the surface zone to volume ratio significantly increased. This authorizes a considerably higher binding capacity of nanoparticles in solutions. The magnetic of nanoparticles, with sizes between 2 and 40 nm show superparamagnetism also they can be magnetized by an external magnetic exporter. The α-Fe2O3 is a canted antiferromagnetic material. This advantage provides additional constancy for magnetic NPs in solutions [13,14]. For the preparation of spherical iron oxide nanoparticles with some minor modifications, but completely different from Chen et al. [15]. In this article, we prepared and characterized a new compound obtained by the bridging, terephthalate, 2-aminothiazole and iron. The resulting complex was applied a precursor for preparation of nanoparticles of iron oxide.

Experimental

Physical Measurements and Materials

The terephthalate, 2-aminothiazole ligands and iron chloride used were commercially available and be given without further purification. The physical measurements in the same in this article [16].

Synthesis of {[Fe(TPA)(AZ)Cl].H2O}n

Preparation of the mixed ligand compound of terephthalate  and 2-aminothiazole with Fe(III) as follows: 

To an EtOH solution 20 ml of iron(III) chloride (0.78 gram , 4.8 mmole) a solution of terephthalate (0.8 gram TPA ligand in 25 ml 0.1 M sodium hydroxide, 4.8 mmol) was added dropwise, and with stirring, then 2-aminothiazole (AZ) solution (0.48 gram in 15 ml EtOH, 4.8 mmol) was added to the mixture. The mixture was refluxed and then cooled. Brown formed separated, which was filtered and washed with ethanol. Anal. Calc. for M.F; C11H10N2SFeClO5 : C, 35.33; H, 2.69; N, 7.49; S, 8.58. Found: C, 36.02; H, 2.87; N, 7.92; S, 8.76. FtIR data: ν OH 3329 (s), ν C=N 1614 (s), ν C-N 818 (s), ν M-O 582 ( m ), ν M-N 418 ( m ) cm-1, m. p. 246 °C and Λm Scm2 mol-1 47.

Formation of Iron Oxide Nanoparticles (IONPs)

Via calcining methods the synthesized complex in air at 550 °C with a calcination time of 180 minutes afforded (IO NPs) iron oxide nanoparticles.

Results and Discussion

Fourier Transform Infrared Spectroscopy (FT-IR)

In the spectrum, as shown below in figure 1, displays a band at 582 cm-1 distinguishing for the iron-oxygen bond vibration in the crystal lattice of IO nanoparticles [17]. Additionally, terephthalate is demonstrated by the appearance of a sharp band with a shoulder in the region 1356 and 1538 cm-1 which indicates symmetric and asymmetric stretching vibration of the COOH groups of the TPA arranged to the iron center. The bands in the area of 1715-1680 cm-1 regularly of protonated COOH groups of TPA were not observed [18]. It is appeared that the CSC band of AZ ligand appearing at 740 cm-1 is nearly unchanged, in the particular iron compound, shown that the thiazol-S is not implicated in the bonding. The stretching vibration of ν(C=N) of thiazole ligand for the complex 1 undergoes no shift comparing to assigned to v(C=N) of the 2-aminothiazole (AZ) (1614cm-1) [19-21].

 

Figure 1: FT-IR of iron oxide nanoparticles (IONPs).

Figure 1: FT-IR of iron oxide nanoparticles (IONPs).

Click here to View Figure

Spectral Analysis

The U.V spectra of the mixed ligand compound and iron oxide nanoparticles are on record in dimethyl sulphuxide. The spectrum of iron complex shown two special bands at 36,836 and 26,246 cm-1, which are ascribe to π →π* and n→ π* transitions within the TPA and AZ organic ligands, respectively. It is apparent that the spectra exhibit a band absorption edge at 354 nm.                   

Magnetic Moments

In the vis. spectra, there was particularity band refered to the d – d transitions in the iron complex typical of octahedral structure (Fig. 2). The d-d band at 19,178 cm-1 was observed for iron complex. The magnetic moment value for the iron compound was 2.82 B.M typical for octahedral complex [22].

Figure 2: Structure of {[Fe(TPA)(AZ)Cl].H2O}n

Figure 2: Structure of {[Fe(TPA)(AZ)Cl].H2O}n

Click here to View Figure

Thermal Analysis 

The thermal analysis of the {[Fe(TPA)(AZ)Cl].H2O}n coordination polymer has been inspected from ambient temperature to 750 °C. Thermogram of iron complex displays four decomposition stages (Fig.3 ), stages at 26-149, 150-277, 278-453 and 454-750 °C. The 1st and 2nd steps correspond to the detachment of the crystalline water molecules (calc. 4.82 %, found 4.70 %). The DTG curve shows this stage in 86 °C and endothermic peaks at  88 °C in the differential thermal analysis (DTA) trace. The 3rd and 4th stages correspond decomposition of the rest of the ligands derivative thermogravimetry peaks at 238, 356 and 456 °C with three exothermic peak in the differential thermal analysis trace at 240, 358 and 458 °C.  The ultimate product at 550°C is consistent with the formation of iron oxide nanoparticles (IONPs).                                                                                                                                 

Kinetic Studies

The non-isothermal kinetic studies of the coordination polymer was carried out, stratify the coats-redfern [23] method. The thermodynamic and kinetic  variables for the iron complex is calculated for the 3rd stage. The 3rd stage shows a non overlapping stage with a derivative thermogravimetry and differential thermal analysis maxima. The negative ∆S* value for the decomposition of the iron coordination polymer propose that the activated compound is more ordered than the organic ligands and iron chloride (reactants) [24]. The more ordered nature may be, due to the polarization of bonds [25] which may be happen through charge transfer (CT) electronic transition. The Positive value of free energy manifest that the decomposition reaction is not spontaneous.

Table 1: Thermodynamic and Kinetic variables for the thermal  decomposition of the iron coordination polymer.

Step

Coats-Redfern equation

∆S*

∆H*

∆G*

r

n

E

Z

3rd

0.9991

0.00

32.8

6.63 x 102

-190.9

26.6

167.5

1.0000

0.33

51.82

10.44 x 102

-187.2

45.6

183.9

0.9996

0.50

64.18

12.90 x 102

-185.6

58.0

195.0

0.9991

0.66

77.97

15.64 x102

-184.1

71.8

207.6

0.9969

1.00

112.21

22.61 x 102

-181.1

106.1

239.7

0.9919

2.00

121.01

48.39 x 102

-175

114.8

244.0

∆G*,∆H*, are in Kilo J. mol-1,  ∆S* in Kilo J. mol-1 K-1 and E in Kilo J. mol-1

Figure 3:  Derivative thermogravimetry and differential thermal analysis  of the iron complex.

Figure 3:  Derivative thermogravimetry and differential thermal analysis of the iron complex.

Click here to View Figure

XRD of Iron Compound and Iron Oxide Nanoparticles (IONPs)

The XRD patterns were recorded for the Fe(III) complex and Fe2O3 nanoparticles (Table 2). The diffraction patterns suggest that the iron complex and Fe2O3 nanoparticles are crystalline, also the crystal lattice variables were registered with the aid of the TREOR program. XRD of compound iron oxide nanoparticles is shown in Fig. 4,  Scherrer’s equation was used to estimate the particle size of the iron complex and iron oxide:                                                                                                                      

(D=Kλ /βcosθ) where, D is the mean size of the ordered (crystalline) domains, λ is the X-ray wavelength typically 1.54 Å, K is the shape factor, β is the line broadening at half the maximum intensity in radians and θ is Bragg angle.

Figure 4:  XRD of iron oxide nanoparticles (IONPs).

Figure 4:  XRD of iron oxide nanoparticles (IONPs).

Click hereto View Figure

Table 2: XRD crystal data of the iron complex and iron oxide.

 

Parameters

Fe(III) complex

Iron oxide

Empirical formula

C11H10N2SFeClO5

Fe2O3

Formula weight

373.55

159.65

Particle size(nm)

48

32

Volume of unit cell(Å3)

654.31

301.72

Crystal system

Triclinic

Hexagonal

α (°)

110.16

90

β(°)

59.95

90

γ(°)

101.29

120

a (Å)

7.06

5.034

b (Å)

8.96

5.034

c (Å)

12.7

13.745

Electron Microscopy (SEM and TEM)

The transmission electron and scanning electron micrographs of Fe2O3 nano-particles (IONPs) are specified in Fig. 5-6. The highly crystalline nature of nanoparticles can be shown from transmission electron microscopy images and electron diffraction photos given in Figure 6.

Figure 5: S.E.M of iron oxide nanoparticles (IONPs).

Figure 5: S.E.M of iron oxide nanoparticles (IONPs).

Click here to View Figure

Figure 6: T.E.M of iron oxide nanoparticles (IONPs).

Figure 6: T.E.M of iron oxide nanoparticles (IONPs).

Click here to View Figure

Antimicrobial Activity

The antimicrobial effectiveness of the iron oxide nanoparticles (IONPs) was inspected against some bacterial and fungal strains [21]. In resulting the antimicrobial effectiveness of the (IONPs) was more than, one examination organism bacteria or fungi to increase the opportunity of discovering the antibiotic principles used in the tested materials, figure (7) show the antimicrobial effect for the (IONPs).

Figure 7: Microbiological screening of the iron oxide  against Staphylococcus aureus Gram-positive.

Figure 7: Microbiological screening of the iron oxide against Staphylococcus aureus Gram-positive.

Click here to View Figure

Conclusion

In this study, we have presented in detail a simplified calcinations method for the formation of high quality magnetic α-Fe2O3 nanoparticles (IONPs) also named hematite. Results of XRD sample display that all peaks, can be well recorded to the phase of hematite. T.E.M and S.E.M micrographs display that there are many micropores through the nanocrystals for the samples calcined at 550 ºC for 180 minute. The particle size of the IONPs in range 13-32 nm.

Acknowledgment

We are grateful for AUMC (Assiut University Mycological Center) in Egypt for supporting this work by doing the antibacterial effectiveness of iron oxide (IONPs) was tested against gram negative -ve and gram positive +ve bacteria.

References

  1. Laurent, S; Forge, D; Port, M. Chemical Reviews. 2008, 108, 6, 2064-2110. 
    CrossRef
  2. Jia, Y; Yuan, M; Yuan, H. International Journal of Nanomedicine, 2012, 7, 1697–1708. 
  3. Park, J; Kadasala, N. R; Abouelmagd, S. A. Biomaterials, 2016, 101, 285–295.
    CrossRef
  4. Sun, Z; Worden, M; Thliveris, J. A. Nanomedicine: Nanotechnology, Biology and Medicine, 2016. 12, 7, 1775-1784. 
    CrossRef
  5. Atta, A. H; El-Ghamry, M. A; Hamzaoui, A; Refat, M. S. Journal of Molecular Structure, 2015, 1086, 246-254. 
    CrossRef
  6. Gupta, A. K; Gupta, M. Biomaterials, 2005, 26, 18, 3995-4021. 
    CrossRef
  7. Karimzadeh, I; Dizaji, H. R; Aghazadeh, M. Journal of Magnetism and Magnetic Materials, 2016, 416, 81-88.
    CrossRef
  8. Augustin, E; Czubek, B; Nowicka, A. M; Kowalczyk, A; Stojek, Z; Mazerska, Z. Toxicology in Vitro, 2016, 33, 45-53. 
    CrossRef
  9. Yin, P. T; Shah, S; Pasquale, N. J; Garbuzenko, O. B; Minko, T; Lee, K.-B. Biomaterials, 2016, 81,  46-57. 
    CrossRef
  10. Mallick, N; Anwar, M.; Asfer, M. Carbohydrate Polymers, 2016, 151, 546-556. 
    CrossRef
  11. Jain, T. K; Foy, S. P; Erokwu, B; Dimitrijevic, S; Flask, C. A; Labhasetwar, V. Biomaterials, 2009, 30,. 35, 6748-6756. 
    CrossRef
  12. Soares, P. I. P; Laia, C. A. T; Carvalho, A. Applied Surface Science, 2016, 383, 240-247.
    CrossRef
  13. Vu-Quang, H; Yoo, M.-K; Jeong, H.-J. ActaBiomaterialia, 2011, 7, 11, 3935-3945. 
    CrossRef
  14. Li, H; Yan, K; Shang, Y. ActaBiomaterialia, 2015, 15, 117-126.
    CrossRef 
  15. Chen, C.J; Chiang, R.K; Lai, H.Y; Lin, C.R. J. Phys. Chem. C, 2010, 114, 4258.
    CrossRef
  16. Maged S. Al-Fakeh, Fahad M. Alminderej, International Journal of ChemTech Research, 2018, 11,05, 442-449.
    CrossRef
  17. Yang, K; Peng, H; Wen, Y; Li, N.  Appl. Surf. Sci. 2010, 256, 3093.
  18. Biemmi, E; Biemmi, T; Stock, N. Solid State Sciences, 2006, 8, 363.
  19. Maurya, R. C; Verma, R;  Singh, H. Synth. React. in Inorg. and Metal-Org. Chem. 2003, 33, 1063.
    CrossRef
  20. Rakha, T. H. Synth. React. Inorg. Met.- Org. Chem. 2000, 30, 205.
  21. . Maged S. Al-Fakeh. Journal of Chemical and Pharmaceutical Research, 2018, 10(2):77-83.
  22. Westerheide, L; Muller, F. K; Than, R; Krebs, B. J. DietrichandSchindler, Inorg. Chem., 2001, 40,1951.
    CrossRef
  23. Coats, A; Redfern, J. Nature., 1964, 20, 68.
    CrossRef
  24. Yusuff, K. M; Karthikeyan, A. R; Thermochim. Acta., 1999, 207, 193-199.
    CrossRef
  25. Emam, M. E; Kanawy, M; Hafe, M. H; J. Therm. Anal. Calorim., 2001, 63, 75-83.
    CrossRef


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.